Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
10.25
+0.23 (2.30%)
At close: Sep 18, 2026, 4:00 PM EDT
10.22
-0.03 (-0.29%)
After-hours: Sep 18, 2026, 7:57 PM EDT
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of $4.64 billion as of September 18, 2026. Its market cap has increased by 477.99% in one year.
Market Cap
4.64B
Enterprise Value
4.39B
1-Year Change
477.99%
Ranking
Category
Stock Price
$10.25
ChartMarket Cap Chart
Since February 26, 2015, Iovance Biotherapeutics's market cap has increased from $244.60M to $4.64B, an increase of 1,798.18%. That is a compound annual growth rate of 28.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 4.64B | 328.44% |
| Dec 31, 2025 | 1.08B | -51.95% |
| Dec 31, 2024 | 2.26B | 8.40% |
| Dec 29, 2023 | 2.08B | 106.29% |
| Dec 30, 2022 | 1.01B | -66.33% |
| Dec 31, 2021 | 3.00B | -55.99% |
| Dec 31, 2020 | 6.81B | 94.85% |
| Dec 31, 2019 | 3.49B | 220.44% |
| Dec 31, 2018 | 1.09B | 87.59% |
| Dec 29, 2017 | 581.10M | 34.67% |
| Dec 30, 2016 | 431.50M | 16.84% |
| Dec 31, 2015 | 369.30M | 50.98% |
| Feb 26, 2015 | 244.60M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PTC Therapeutics | 5.46B |
| Dianthus Therapeutics | 5.42B |
| Definium Therapeutics | 5.21B |
| Erasca | 5.17B |
| Parabilis Medicines | 5.16B |
| Edgewise Therapeutics | 4.92B |
| ACADIA Pharmaceuticals | 4.70B |
| Veradermics | 4.46B |